SAS Output

26-MAY-2017 18:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9138 812 403 219 82 19 02/28/2011 430 214
            9138 812 403 219 82 19      
 
    2 Y 2 Chemo and Endocrine Therapy 4000 2452 274 125 73 27 4 02/28/2011    
        3 Endocrine Therapy Alone   2443 275 131 78 28 7      
            4895 549 256 151 55 11      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 618 227 115 63 18 5 09/12/2013 482 246
        2 Blinded drug + Endocrine   612 222 110 60 19 4      
            1230 449 225 123 37 9      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 17 6
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 43 43 38 26 8 3 09/15/2016 248 119
        2 Blinded Drug + Cisplatin   43 43 39 25 10 4      
            86 86 77 51 18 7      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 32 32 32 26 14 4 01/18/2017 314 126
            32 32 32 26 14 4      
 
    2 Y 2 Observation 1000 11 11 11 11 7 4 01/18/2017    
        3 MK-3475 (Pembrolizumab)   13 13 13 10 7 2      
            24 24 24 21 14 6      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   38 19 10 8 4 1 04/29/2014 260 121
            38 19 10 8 4 1      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   142 11 4 4 2 0 08/13/2013 256 92
            142 11 4 4 2 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   117 46 29 13 6 1 03/20/2014 364 194
            117 46 29 13 6 1      
 
    1 E Total Registrations   49 21 12 6 3 0 03/20/2014    
            49 21 12 6 3 0      
 
  A011203-Breast, Adv, Tam vs Endoxifen 0 E Total Registrations   9 1 1 1 0 0 08/14/2015 240 90
            9 1 1 1 0 0      
 
    1 E Total Registrations   7 1 1 1 0 0 08/14/2015    
            7 1 1 1 0 0      
 
    2 E Total Registrations   2 0 0 0 0 0 08/14/2015    
            2 0 0 0 0 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   37 37 33 19 8 2 10/05/2016 246 126
            37 37 33 19 8 2      
 
    2 E Total Registrations   27 27 26 14 4 2 10/05/2016    
            27 27 26 14 4 2      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   13 5 5 2 1 1 06/13/2014 437 216
            13 5 5 2 1 1      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   40 23 13 5 2 1 12/15/2014 407 185
            40 23 13 5 2 1      
 
    2 E Total Registrations   15 7 5 1 0 0 12/15/2014    
            15 7 5 1 0 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   32 17 8 3 1 0 04/01/2015 297 163
            32 17 8 3 1 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   9 6 4 4 1 0 11/12/2015 258 133
            9 6 4 4 1 0      
 
    1 P Total Registrations   1 1 0 0 0 0 11/12/2015    
            1 1 0 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   34 20 11 8 6 2 10/16/2015 441 216
            34 20 11 8 6 2